Knocking down Cldn3 and Cldn4 expression appears to be androgen independent as both human prostate cancer cell lines PC3 (androgen independent) and LNCaP (androgen dependent) had similar growth outcomes. The gene discussed is CLDN4; the disease is Familial prostate cancer.